Association study of LMP-1 expression and promoter methylation status of tumor suppressor gene RASSF1A in nasopharyngeal carcinoma by Harijadi, Rina Susilowati, Ageng Brahmadhi Susanna Hilda Hutajulu, Dewi Kartika
31
Brahmadhi et al, Association study of LMP-1 expression and promoter methylation status of tumor suppressorJ Med Sci
Volume 43, No. 1, March 2011: 31-37
* corresponding author: aghie666@yahoo.com
Association study of LMP-1 expression and
promoter methylation status of tumor
suppressor gene RASSF1A in
nasopharyngeal carcinoma
Ageng Brahmadhi1, Susanna Hilda Hutajulu2,3, Dewi Kartika Paramita3,4, Harijadi5,
Rina Susilowati3*
1Master Student of Biomedical Science, 2Department of Internal Medicine,
3Molecular Biology Laboratory, 4Department of Histology and Cell Biology,
5Department of Anatomy Pathology, Faculty of Medicine, Gadjah Mada University, Yogyakarta,
Indonesia
ABSTRACT
Nasopharyngeal carcinoma (NPC) is a cancer originating from nasopharyngeal epithelial tissue. Genetic susceptibility,
exposure to carcinogens, and Epstein-Barr virus (EBV) infection are the main factors in NPC development. Latent
membrane protein 1 (LMP-1) is a product of EBV genome, which is able to interact with various intracellular signaling
pathways that leads to expression of many proteins, e.g DNA methyltransferase. The increase expression of DNA
methyltransferase could induce hypermetylation of tumor suppressor genes (TSG). Ras-association domain family
1A (RASSF1A) is one of TSG that frequently hypermethylated in NPC cases. The aim of this study is to determine
the association between LMP-1 expression and promoter methylation status of RASSF1A in NPC patients. The
research subjects were 36 NPC patients of the Dr. Sardjito Hospital, Yogyakarta, Indonesia. Latent membrane
protein 1 was stained immunohistochemically using monoclonal antibody OT21C. Ras-association domain family 1A
methylation status was examined by methylation specific PCR (MSP) of DNA isolated from nasopharyngeal brushing.
Chi-square analysis was conducted to examine the association between LMP-1 expression and methylation status of
RASSF1A with 95% confidence interval. Latent membrane protein 1 was expressed in 44.4% subjects. The scores
of LMP-1 expression were ranged from 0-8 (average of 1.56 ± 2.16). Ras-association domain family 1A methylated
in 66.7% of subjects. Statistical analysis showed that there was a relationship between LMP-1 expression and
methylation status of RASSF1A (p<0.05). Statistical analysis also showed association between LMP-1 expression
score and RASSF1A methylation status (p<0.05). It can be concluded that there was an association between the
expression of LMP-1 and RASSF1A methylation status in NPC patients.
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INTRODUCTION
Nasopharyngeal carcinoma (NPC) is cancer
originated from nasopharyngeal squamous epithelial
cells. The incidence of NPC is scattered in distinct
populations in several areas world wide, such as
China, East Asia, Southeast Asia, Artic, Alaska,
North Africa and North America.1 This incidence
pattern indicates the contributions of genetic and
environmental factors in the development of this
cancer.1 However 95% NPC cases are related to
Epstein-Barr virus (EBV) infection which indicates
that EBV is a primary factor in NPC development.2,3
Epstein-Barr virus is a DNA virus that infects
more than 90% of the adult population, and the
infection lasts for lifetime. Several diseases are
known as EBV associated diseases e.g infectious
mononucleosis, Hodgkin’s disease, Burkitt’s
lymphoma, NPC, oral hairy leukoplakia, and
undifferentiated gastric carcinoma.4 Epstein-Barr
virus is potential to be considered as anorganic virus
due to the expression of EBV latent genes such as,
latent membrane proteins (LMP-1, LMP-2A and
LMP-2B) and core antigens (EBNA 1 and EBNA2).
LMP-1 is the main oncogene that play a role in
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NPC cells immortalization. Latent and expresed in
80-90% of NPC. Latent membrane protein 1
allegedly associated with inhibition of transcription
and inactivation of TSG through hyper-
methylation.5,6 Hypermethylation of several TSGs
in NPC cases have been reported, including
hypermethylation of RASSF1A (66.7% -84%),
death-associated protein kinase (DAP-kinase)
(76%), p16 (46%), tumor suppressor in lung cancer
1 (TSLC1), retinoic acid receptor beta (RAR)
(80%), methylguanine DNA methyltransferase
(MGMT) (20%) and glutathione S-transferases
(GSTP) (13%).7-10
Ras-association domain family 1A inactivation
has been reported in various types of tumors.11 It
has a major role in intracellular signal transduction
pathways, such as apoptosis, cell cycle arrest and
cell migration.3,11 When RASSF1A is
hypermethylated, the RASSF1A expression is
silenced. The lack of RASSF1A expression in a cell
will develop unregulated proliferation. The loss of
RASSF1A expression also causes the cell to migrate
easily, leading to tissue invasion or metastasis.11
Therefore, to increase further understanding about
NPC carcinogenesis, this study aims to determine
whether there is any association between LMP-1
expression with methylation status of RASSF1A in
NPC patients.
MATERIALS AND METHODS
Subjects
The subjects of this study were NPC patients
at Dr. Sardjito Hospital, Yogyakarta, Indonesia in
2003-2009. The subjects were diagnosed by
otolaryngologist based on result of CT-scan and
biopsy examination. Based on Estimated Difference
Proportion calculation,12 the minimum number of
subjects for this study was 20 subjects. Stages of
cancer were classified by TMN method based on
classification of the American Joint Committee on
Cancer (AJCC).13 Stage I and II were classified as
early stage, while stage III and IV were classified as
late stage.14,15 Paraffin blocks of nasopharyngeal
biopsy were prepared for histopathological and
immunohistochemical examination. Nasopharyngeal
brushing was performed and DNA extracted with
Boom’s method.16 This study has been approved
by The Ethics Research Committee of Faculty of
Medicine, Gadjah Mada University, Yogyakarta.
LMP-1 immunohistochemistry
Nasopharyngeal carcinoma paraffin blocks were
sliced in 5 m thickness, then placed on object
glass. The specimens were stained with Streptavidin-
Biotin labeled method to determine LMP-1
expression 140Antibody of OT21C kindly provided
by Professor Jaap Middeldorp (Vrije Universiteit
EBV Group Medisch Centrum/VUMC, Amster-
dam). LMP-1 positive control was obtained from
tissue that was known expressing LMP-1. Whereas
the negative control was samples without OT21C
monoclonal antibody. Positive LMP-1 expression
was marked by the appearance of brown color in
the cytoplasm. LMP-1 expression examination was
carried out on five visual field by three examiners,
and the scoring expression score was calculated
quantitatively based on color intensity and
percentage of immunopositive cells per visual field
with a scale of 0-12 according to the previous
studies.8,17 For analysis, LMP-1 expression scores
were grouped into low expression, middle expression
and high expression groups. Cut point was
determined by Binning method using SPSS. Latent
membrane protein 1 expression score of less than 1
was grouped in low expression group, and LMP1
expression score of 1-3 was grouped in middle
expression. While the expression score more than 3
was grouped in the high expression group.
RASSF1A methylation specific PCR
The isolated DNA samples were modified using
the Zymo EZ DNA methylation kit (Zymo Cat. No:
D5001). Methylated specific PCR (MSP) primer
sequences were GTGTTAACGCGTTGCGTATC
(F) andAACCCCGCGAACTAAAAACGA(R) with
product size of 95 base pairs (bp). Unmethylated
specific PCR (USP) primary sequence used were
TTTGGTTGGAGTGTGTTAATGTG (F) and
CAAACCCCACAAACTAAAAACAA (R) with
product size of 105 bp. Methylated specific PCR
amplification was performed using PE-9600. PCR
was performed for 45 cycles, with annealing
temperature at 60 °C for one minute. PCR products
were analyzed by gel electrophoresis, using 2%
agarose gel. DNA of patients with known positive
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NPC MSP and USP was used as positive control
for MSP and USP. While the negative control used
PCR mix without template. To analize product of
PCR, Fermentas FastRuler ™ Low Range DNA
Ladder (Fermentas Cat. No: # SM1103) was used
as DNA ladder.
Statistical analysis
Association between methylation status of
tumor suppressor gene RASSF1A and LMP-1
expression was analyzed by Chi-square with 95%
confidence interval. Chi square analysis was also
conducted to determine the association between
RASSF1A methylation status with age and stage of
the subject.
RESULTS
Subjects characteristics
The subjects in this study were 36 subjects
aged 26-72 years with an average age of 47.55 years.
Most of the subjects was male (72.2%). The results
showed that 88.9% of research subjects were at an
advanced stage (stage III and IV).
LMP-1 expression examination
The LMP-1 immunohistochemistry staining
showed the variation of LMP-1 expression
(FIGURE 1). The LMP-1 expression intensity
varied in each subject. The weak, medium and
strong intensities were found in the subjects being
examined. In some subjects, LMP-1 was expressed
uniformly at the entire field examined. While on the
other subject, LMP1 was expressed in a scattered
or expressed in a group at a particular location.
Sixteen subjects (44,4%) expresed LMP-1
(expression score1). Among them, 14 subjects
were in advanced stage. The LMP-1 expression
score obtained was ranged between 0-8, with an
average value of 1.56 ± 2.16.
FIGURE 1. Immunohistochemistry staining of latent membrane protein 1 in NPC biopsies. Positive LMP-1 expression was
marked by the appearance of brown color on the cytoplasm. Figure A showed no expression of LMP-1. B, Arrow indicating
Expression of LMP-1 with weak color intensity. C, Arrow indicating expression of LMP-1 intermediate level and spread >50% of
the visual field. D, expression of LMP-1 with strong intensity and spread >75% field of view. White arrow show the representa-
tive area of LMP-1 expression (magnification 400x).
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RASSF1A methylation status
Methylated specific PCR results showed that
hypermethylation of RASSF1A occurred in 24
subjects (66,7%). Figure 2 represented the results
of RASSF1A MSP NPC patients. PCR band in MSP
was an indicator that hypermethylation occurred in
the sample. In case PCR band appeared in both
USP and MSP, sample was considered as
hypermethylated since there was possibility that the
sample also contaminated cells. Figure 2 showed
that RASSF1A hypermethylation occured in the
subject no 1 and 3, while the subject no 2 was
unmethylated.
FIGURE 2. The results of RASSF1A MSP electrophoresis.
RASSF1A hypermethylation occured in subject no. 1 and 3.
While subject no. 2 was unmethylated.
Association of LMP-1 expression and
RASSF1A methylation status
Table 1 showed the distribution of LMP-1
expression and methylation status of RASSF1A.
Latent membrane protein 1 positive subject had more
RASSF1A hypermethyation compared to LMP-1
negative subject. Fourteen subjects of 16 LMP-1
positive subjects had RASSF1A hypermethylation.
On the other hand, 10 out of 20 LMP-1 negative
subjects had RASSF1A hypermetylation.
Variable n
MSP RASSF1A
χ2 p
Unmethylated Methylated
LMP-1
expression
5.625 0.018 Positive 16 2 14
 Negative 20 10 10
Phi value = 0.395
TABLE 1. Chi square analysis of LMP-1 expression with
RASSF1A methylation status
Chi-square analysis was conducted to determine
the association between LMP-1 expression with
RASSF1A methylation status. The Chi-square test
results showed that there was an association between
expression of LMP-1 with RASSF1A methylation
status (p= 0.018) and phi value was 0.395. The
result indicated that there was a tendency that
RASSF1A hypermethylation occured in LMP-1
positive subjects.18 To further analyzed the
association between LMP-1 expression score with
RASSF1A methylation status, LMP-1 expression
score were grouped into low, middle and high
expressions. Data were analyzed using cross
tabulation to determine the association between the
score of LMP-1 expression with methylation status
of RASSF1A. Table 2 showed that there was an
association between the score of LMP-1 expression
with RASSF1A methylation status (p=0.010).
Table 2. Chi square analysis of LMP-1 expression score
with RASSF1A methylation status.
Variable n
MSP RASSF1A
χ2 p
Unmethylated Methylated
LMP-1 expression
score
8.100 0.017
 Low (score
<1)
20 10 10
 Mid (score 1-
3)
5 2 3
 Negative
(score≥3)
11 0 11
Fisher’s exact test 8.95 0.10
Phi value = 0.474
DISCUSSION
Examination of LMP-1 Expression
Latent membrane protein 1 expression was
detected in 44.4% research subjects. This frequency
was lower than the range of frequencies that have
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been reported which ranged from 50-100%.8,17,19
Latent membrane protein 1 expression score in this
study ranged between 0-8 of the maximum score
(12) that can be obtained. This score was lower
than previous studies. By using the same method,
Hariwiyanto17 reported that LMP-1 expression score
ranged from 2-12 with an average of 7.6 (± SD =
2.6). While other studies reported that LMP-1 score
ranged from 3-11.8
The different LMP-1 expression score in this
study, possibly caused by the differences in types
of antibody used. The antibody used to detect the
expression of LMP-1 in this study was a monoclonal
antibody that recognized a conformational epitope
at residues 290 to 318, overlapped with 11 amino
acid repeat in LMP-1.20 Khabir et al.,8 and
Hariwiyanto,17 used antibodies CS1-4. The CS1-4
was a pool of four types of monoclonal antibodies
that recognized the C-terminus of LMP-1. The target
was the variable region epitopes on 11 amino acids
between residues 205 to 308, and also at 386 the
end residue of C-terminus.21,20 Different target
antigen epitopes influenced the sensitivity and
specificity of antibodies, it was influential on the
final assessment of LMP-1 expression.7
Jiwa et al.,7 reported that there were different
immunoreactivity between CS1-4 monoclonal
antibody with the S12 (OT17). The S12
monoclonal antibody was known to be more
sensitive in detecting LMP-1 compared with CS1-
4. The S12 also provided better color and contrast
than CS1-4. Based on author’s knowledge, research
on immunoreactivity comparison between antibody
CS1-4 with OT21C has never been done, therefore
the level of sensitivity between the two antibodies
can not be compared.
RASSF1A methylation status
In this study, RASSF1A hypermethylated in
66.7% subjects. This was in line with previous
studies which reported that the frequency of
RASSF1A hypermethylation in NPC ranged from
66.7%-84%.2,7,12 Statistical analysis showed that
there was no relationship between RASSF1A
methylation status with age of study subjects (p =
0.637). The RASSF1A methylation status was also
not associated with stage NPC subjects (p = 0.708).
The result was in contrast with previous studies
which stated that the incidence of TSG promoter
methylation increased with the increasing age of
subjects.4,11,21-23
Association of LMP-1 expression and
RASSF1A methylation status
The result successfully demonstrated the
relationshipbetweenLMP-1expression inNPCbiopsy
withhypermethylationofRASSF1Apromoter inDNA
that was isolated from nasopharyngeal brushing. The
result showed a tendency of hypermethylation of
RASSF1AinsubjectwithhighLMP-1expressionscore.
This result indicated that LMP-1 expression can be
used as marker of RASSF1A hypermethylation
incidence. However, intracellular mechanismof LMP-
1 in inducing RASSF1A hypermetylation still need
further study.
Latent membrane protein 1 is known to induce
tumor suppressor genes hypermetylation through
DNA methyltransferase (DNMT1, and DNMT3b
DNMT3a) activities.24,25 There was a report of
phosporylation of DNA methyltransferase by LMP-
1 signaling via c-Jun NH2-terminal kinase (JNK).26
The LMP-1 activates JNK, and phosphorylates
transcription factor c-Jun. The phosphorylated c-
Jun binds the activator protein 1 (AP-1) and
transactivates the DNMT1 promoter. Elevated
DNMT1 expression leads to hypermethylation of
TSG.6 In addition, LMP-1 may inhibit expression
of RASSF1A through the NF-B. 20 If the
mechanism of LMP-1 in inducing hypermethylation
RASSF1A can be recognized, it will be very useful
in the development of therapeutic agents. This will
open the possibility of application of 3,4-
dihydroxybenzalacetone (DBL) for inhibiting NF-
B,27 or application of azacytidine to inhibit DNA
methyltransferase 28 activity as one of the NPC
therapies.
CONCLUSION
There was an association between expressions
of LMP-1 with RASSF1A methylation status in
NPC patients.
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